(Q34632472)

English

An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions (English)

1 reference

Europe PubMed Central

3 August 2017

1 reference

based on heuristic

inferred from title

pancreatic adenocarcinoma

1 reference

based on heuristic

inferred from title

Erin E Salo-Mullen

object named as

Erin Salo-Mullen

8

0 references

object named as

Maeve A Lowery

1

0 references

object named as

Mark E Robson

9

0 references

Eileen M. O'Reilly

object named as

Eileen M O'Reilly

12

0 references

Zsofia K. Stadler

3

object named as

Zsofia K Stadler

1 reference

Europe PubMed Central

3 August 2017

author name string

David P Kelsen

2

1 reference

Europe PubMed Central

3 August 2017

Kenneth H Yu

4

1 reference

Europe PubMed Central

3 August 2017

Yelena Y Janjigian

5

1 reference

Europe PubMed Central

3 August 2017

Emmy Ludwig

6

1 reference

Europe PubMed Central

3 August 2017

David R D'Adamo

7

1 reference

Europe PubMed Central

3 August 2017

Peter J Allen

10

1 reference

Europe PubMed Central

3 August 2017

Robert C Kurtz

11

1 reference

Europe PubMed Central

3 August 2017

publication date

20 September 2011

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

16

1 reference

Europe PubMed Central

3 August 2017

1397-1402

1 reference

Europe PubMed Central

3 August 2017

10

1 reference

Europe PubMed Central

3 August 2017

Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228075

7 July 2018

Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspective.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228075

7 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228075

7 July 2018

BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228075

7 July 2018

A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228075

7 July 2018

Resistance to therapy caused by intragenic deletion in BRCA2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228075

7 July 2018

BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of Poly (ADP-Ribose) polymerase: an issue of potency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228075

7 July 2018

Cancer risks in BRCA2 mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228075

7 July 2018

Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228075

26 October 2018

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228075

26 October 2018

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

1 reference

https://pubmed.ncbi.nlm.nih.gov/21934105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRCA2 germline mutations in familial pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21934105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1634/THEONCOLOGIST.2011-0185

1 reference

Europe PubMed Central

3 August 2017

release_fq4zh4ck6ra7vafe5wad4hpigq

1 reference

https://api.fatcat.wiki/v0/release/fq4zh4ck6ra7vafe5wad4hpigq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34632472&oldid=2046352542"